Xiangzhan Kong
-
- Cancer, Hypoxia, and Metabolism 3
-
- Cancer Cells and Metastasis 3
- Pancreatic and Hepatic Oncology Research 2
-
- Immune cells in cancer 3
- Phagocytosis and Immune Regulation 2
- Immunotherapy and Immune Responses 2
-
- Sphingolipid Metabolism and Signaling 3
-
- Ferroptosis and cancer prognosis 2
- Co-authors
- Ping‐Pui WongCheng HuangXiaoyi QiuRuipu SunXinbao ZhaoLiangping SuYitian ChenXue Jiang
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Nature Communications (2 papers)Science Translational Medicine (1 paper)Cardiovascular Research (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiangzhan Kong
19 papers receiving 427 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 129
- Oncology 144
- Immunology 80
- Molecular Biology 223
- Parasitology 18
Countries citing papers authored by Xiangzhan Kong
This map shows the geographic impact of Xiangzhan Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangzhan Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangzhan Kong more than expected).
Fields of papers citing papers by Xiangzhan Kong
This network shows the impact of papers produced by Xiangzhan Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangzhan Kong. The network helps show where Xiangzhan Kong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiangzhan Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 10 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 87 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 82 | |
| 12 | 2021 | 33 | |
| 13 | 2021 | 66 | |
| 14 | 2020 | 33 | |
| 15 | 2020 | 2 | |
| 16 | 2017 | 5 | |
| 17 | 2016 | 23 | |
| 18 | 2007 | 36 | |
| 19 | [The application of high molecular weight cytokeratin in differential diagnosis of prostate adenocarcinoma]. | 1996 | 1 |
| 20 | Evaluation of hepatocyte growth-promoting factors in treating 1687 cases of fulminant hepatitis. | 1995 | 4 |
About Xiangzhan Kong
Xiangzhan Kong is a scholar working on Cancer Research, Oncology and Immunology, having authored 21 papers that have together received 433 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (3 papers), Cancer Cells and Metastasis (3 papers), Immune cells in cancer (3 papers), Sphingolipid Metabolism and Signaling (3 papers), Ferroptosis and cancer prognosis (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Phagocytosis and Immune Regulation (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Cancer Research (129 citations), Oncology (144 citations) and Immunology (80 citations). Xiangzhan Kong has collaborated with scholars based in China and United States. Frequent co-authors include Ping‐Pui Wong, Cheng Huang, Xiaoyi Qiu, Ruipu Sun, Xinbao Zhao, Liangping Su, Yitian Chen, Xue Jiang, Ya-Ming Meng and Qiong Meng. Their work appears in journals such as Nature Communications, Science Translational Medicine and Cardiovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.